Navigation Links
South Carolina Dermatologists Will Serve Tennis Fans With Free Skin Checks and Sun Safety Tips
Date:4/13/2009

l USA, headquartered in New York City, is a wholly owned subsidiary of L'Oreal SA, one of the world's leading beauty companies. L'Oreal USA has Research and Development, Manufacturing and Distribution facilities across eight states in the U.S, including New York, New Jersey, Kentucky, Arkansas, Illinois, Ohio, Colorado and Texas. L'Oreal's impressive portfolio of brands includes Lancome, Giorgio Armani, Shu Uemura, L'Oreal Paris, Garnier, Vichy, La Roche-Posay, L'Oreal Professionel and Kerastase. The U.S. is the base for the product development, international marketing and advertising for L'Oreal's nine American brands: Maybelline New York, Soft-Sheen, Carson, Kiehl's Since 1851, Ralph Lauren Fragrances, Redken 5th Avenue NYC, Matrix, Mizani, SkinCeuticals and PureOlogy.


'/>"/>
SOURCE Women's Dermatologic Society
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
2. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
3. DNC: South Carolina Rejecting Romneys Smooth Talk on Health Care
4. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
5. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
6. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
7. South Texas Doctors Report More Severe Cases of Community Staph Super Bug Hospitalizing Children
8. ASTRO, Wellness Community South Bay Cities Join to Promote Cancer Survivorship
9. USAID Assistant Administrator Hess Travels to Southern Africa
10. IMA South American Extravaganza Dinner to Honor Coachella Valley Doctor
11. Medical University of South Carolina Leads Multicenter Study Evaluating Biliary Sphincter Disorder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...lar cancer who were treated with cisplatin-based c...g neurological side effects and Raynaud-like pheno...apy, according to a new study published online Nov...stitute . , Marianne Brydy, M.D., of the Departm... Bergen, Norway, and colleagues conducted a cross-...
(Date:11/25/2009)...grew out of a collaboration between UCLA engineers...e nearly 10 million Americans who suffer from peri...dening of the arteries, peripheral arterial diseas...h narrowed arteries reduce blood flow to the limbs...lar disease, heart attack and stroke, and its prog...
(Date:11/25/2009)...oo short to draw definite conclusions, experts say...s) -- In diabetic patients with blocked coronary a...omes at one year whether patients undergo bypass s...rchers report. , Bypass surgery has been the st...ry artery disease. However, less invasive approach...
(Date:11/25/2009)...tion and treatment clinics to resume Monday, Nov. ...vember 25, 2009 -- Centegra Health System is conti...e shots at four Centegra Primary Care (CPC) vaccin...s arrived. The clinics are at CPC sites in Huntley...open as follows: ,   From 4:30 to 7:30...
(Date:11/25/2009)...logical symptoms, study finds , , WEDNE...e effects are among the potential problems faced b...e treated with cisplatin-based chemotherapy, a new...rwegian men treated for unilateral testicular canc...-up survey conducted from 1998 to 2002. , The r...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
... Fair 2008 to Focus on Wellness,and Safety, NEW Y...he Montefiore Medical Center:, WHAT:, For famili...mes for,this year,s Keeping Kids Healthy Children,...Hospital at Montefiore,Mosholu-Montefiore Communit...
...,Biomedical Excellence for Safer Transfusion (BEST...garding the scientific validity and medical,implic... that transfusion,of older units of Red Blood Cell...isory Committee on Blood Safety and,Availability (...
...y Jubilant, TORONTO, May 27 /PRNewswire-FirstCall...AQ: DRAX ) announced today that it has obtained a...nection with the previously,announced proposed sta..."Jubilant") for US$6.00 per common share. The,arra...
...in arteries rather than amount , , TUESDA...of a person,s heart attack risk can be achieved us...ount not only the amount, but also the distributio...cularly important in estimating a patient,s potent...
... any increased risk, researchers find , ,...he patients with a history of heart disease are un...on,t see themselves being at increased risk for on...isk of having a heart attack or dying, compared wi...
...um GmbH have today signed a contract worth 263 mil... Earth Explorer mission of ESAs Living Planet Prog...sible for the satellites design, development and i... of Earth Observation, Evert Dudok, CEO of Astrium...
Other Medicine News:Health News:International Research Organization Responds to Recent Studies Purporting to Show That Transfusion of Older Red Blood Cells Leads to Greater Risk 2Health News:International Research Organization Responds to Recent Studies Purporting to Show That Transfusion of Older Red Blood Cells Leads to Greater Risk 3Health News:DRAXIS Obtains Final Order for Proposed Arrangement 2Health News:DRAXIS Obtains Final Order for Proposed Arrangement 3Health News:DRAXIS Obtains Final Order for Proposed Arrangement 4Health News:New Calcium Measure Better Predictor of Heart Risks 2Health News:Many With Heart Disease Don't Know Signs of Heart Attack 2Health News:Many With Heart Disease Don't Know Signs of Heart Attack 3Health News:EarthCARE satellite contract signed 2
(Date:11/25/2009)...YORK,Nov.25/PRNewswire/--Reportlinker.comannounces...gue: ,, PainManagement-GlobalTrends ,, ...nt---Global-Trends.html ,, Widespreadavailabil...,andtheadventofnewdrugshaveacceleratedthepaceofgro...eimbursementstructurecontinuetoshapedemandforservi...
(Date:11/25/2009)...FT,TheNetherlandsandJOHANNESBURG,November25/PRNews...yxisDiscoveryannouncedtoday,thattheyhavesignedacol...ervices. , Pyxis,sworldclasscomputationalchem...hemba,sservicedivisiontoprovidemedicinaland,synthe...s,internationalclientnetwork.iThembaPharmaceutica...
(Date:11/25/2009)...NTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCentry...omtheCompany,sPROTECT-1(theProspectiveRandomizedOr...t-EN(TM)(CCX282-B)inpatientswithmoderate-to-severe...orablesafetyandtolerabilityprofile.Thestudydemonst...easeseverityasdefinedasa70-pointdecreaseintheCrohn...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Greenway Medical Technologies EHR Solution PrimeSuite Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Science 53493 1Greenway Medical Technologies EHR Solution PrimeSuite Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Science 53493 2Greenway Medical Technologies EHR Solution PrimeSuite Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Science 53493 3Greenway Medical Technologies EHR Solution PrimeSuite Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Science 53493 4Researchers effectively treat tumors with use of nanotubes 53492 1Researchers effectively treat tumors with use of nanotubes 53492 2Researchers effectively treat tumors with use of nanotubes 53492 3Unlocking the key to human fertility 53490 1Unlocking the key to human fertility 53490 2Unlocking the key to human fertility 53490 3
Ovation BioNatural Pipette, one-stroke, fixed volume, 200L
Finnpipette Fixed Volume, 200ul
Pipetman F100
Eppendorf Research Series 2100 Fixed-volume Pipette, 100 l
Medicine Products: